Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Volume: 49, Issue: 1, Pages: 126 - 135
Published: Aug 1, 2019
Abstract
Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical practice Methods: Observational, open-label multicenter study from 40 national referral centers of GCA patients treated with TCZ due to inefficacy or adverse events of previous therapy. Outcomes variables were improvement of...
Paper Details
Title
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Published Date
Aug 1, 2019
Volume
49
Issue
1
Pages
126 - 135
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.